Clariant’s Care Chemicals expands production capabilities in China as part of growth strategy
Clariant’s Care Chemicals recently unveiled its expanded facilities in Daya Bay, China, which it says will play a crucial role in the company’s growth strategy in Asia.
The expansion, which involved an investment of CHF80m (USD99.8m), is set to substantially boost Clariant’s manufacturing capabilities in one of its key growth markets, particularly China’s rapidly evolving specialty chemicals sector.
Specifically, the newly opened facilities will improve the company’s production capabilities in two main areas — pharmaceutical excipients, and specialty chemicals for personal and home care applications.
Cosmetics, beauty devices lead APR Corp’s ‘record-breaking’ performance in Q3 2025
South Korean firm APR Corp says that its cosmetics and beauty divisions were key growth drivers for the third quarter of 2025, leading to record-breaking financial results it recently announced.
According to its provisional consolidated earnings report, APR Corp recorded revenue of KRW385.9bn (USD267m) and operating profit of KRW96.1bn (USD66.5m) for Q3 2025.
These figures represent year-over-year growth of 122% in revenue and 253% in operating profit, marking the company’s highest quarterly performance to date.
Lotus Professional capitalises on hybridisation of beauty as ‘profit multiplier’
Lotus Professional is capitalising on the increasing hybridisation of beauty as a “profit multiplier” by doubling down on in-salon technologies alongside at-home care products.
A division within Lotus Herbals, Lotus Professional recently marked its 20th anniversary with a celebratory event in Armenia, where its latest innovations were unveiled. These include new facial treatments and Water Burst Range for advanced hydrating barrier repair.
These launches represented the brand’s philosophy of combining advanced actives with green science to deliver skin care that is both results-driven and sensorial.
Galderma enters China amid surging demand for peri- and postoperative skin care
Swiss company Galderma released four core products under the Alastin brand in China in September, marking its debut in one of the world’s fastest-growing aesthetic skin care markets.
Targeted at addressing the surge in demand for peri- and postoperative management, the products are designed to cover all stages of the aesthetic journey — from pre-treatment preparation to post-procedure recovery and at-home maintenance skin care.
The increasing demand is driven by several factors, including a rapid rise in China’s medical aesthetics market, with projections indicating up to 15% annual growth in the next decade.
Vow ventures into functional cosmetics, unlocks new frontier in biotech beauty
Sydney-based biotech firm Vow has set foot into the functional cosmetic ingredients space with an upcoming debut of its cultured exosome targeting skin regeneration at a biological level.
After the introduction of its cultured meat brand Forged, Vow has been working on new applications of cell culture technology, extending its platform to develop functional ingredients for the beauty, health, and pet nutrition industries.
According to the company, the expansion into functional beauty is a “natural evolution”, leveraging its expertise in cell biology and large-scale biomanufacturing to unlock cultured exosome technology for the next era of skin health.
